Co-crystal structures of inhibitors with MRCKβ, a key regulator of tumor cell invasion
| Autor: | Mathew Rushbrooke, Ewald Schroder, Edward R. Wheatley, Sarah J. Kaye, Diane Crighton, Michael F. Olson, Mokdad Mezna, Timo Heikkila, Alexandra Boakes, Leon Pang, Andrew P. Turnbull |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2011 |
| Předmět: |
Models
Molecular Myosin light-chain kinase Pyridines lcsh:Medicine Thiophenes GTPase Biology Crystallography X-Ray Biochemistry Myotonin-Protein Kinase Serine Inhibitory Concentration 50 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine Catalytic Domain Cell Line Tumor Drug Discovery Molecular Cell Biology Humans Neoplasm Invasiveness lcsh:Science Protein Kinase Inhibitors Cytoskeleton rho-Associated Kinases Multidisciplinary Kinase Myotonin-protein kinase lcsh:R Protein-Tyrosine Kinases Ligand (biochemistry) Amides Cellular Structures Extracellular Matrix Cell biology Drug Combinations Protein kinase domain Small Molecules Phosphorylation Proteoglycans lcsh:Q Collagen Laminin Protein Multimerization Research Article Signal Transduction |
| Zdroj: | PLoS ONE, Vol 6, Iss 9, p e24825 (2011) PLoS ONE |
| ISSN: | 1932-6203 |
| Popis: | MRCK alpha and MRCK beta (myotonic dystrophy kinase-related Cdc42-binding kinases) belong to a subfamily of Rho GTPase activated serine/threonine kinases within the AGC-family that regulate the actomyosin cytoskeleton. Reflecting their roles in myosin light chain (MLC) phosphorylation, MRCK alpha and MRCK beta influence cell shape and motility. We report further evidence for MRCK alpha and MRCK beta contributions to the invasion of cancer cells in 3-dimensional matrix invasion assays. In particular, our results indicate that the combined inhibition of MRCK alpha and MRCK beta together with inhibition of ROCK kinases results in significantly greater effects on reducing cancer cell invasion than blocking either MRCK or ROCK kinases alone. To probe the kinase ligand pocket, we screened 159 kinase inhibitors in an in vitro MRCK beta kinase assay and found 11 compounds that inhibited enzyme activity >80% at 3 mu M. Further analysis of three hits, Y-27632, Fasudil and TPCA-1, revealed low micromolar IC(50) values for MRCK alpha and MRCK beta. We also describe the crystal structure of MRCK beta in complex with inhibitors Fasudil and TPCA-1 bound to the active site of the kinase. These high-resolution structures reveal a highly conserved AGC kinase fold in a typical dimeric arrangement. The kinase domain is in an active conformation with a fully-ordered and correctly positioned alpha C helix and catalytic residues in a conformation competent for catalysis. Together, these results provide further validation for MRCK involvement in regulation of cancer cell invasion and present a valuable starting point for future structure-based drug discovery efforts. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|